Antidiabetic Drugs Present and Future
- 1 November 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 60 (5) , 1017-1028
- https://doi.org/10.2165/00003495-200060050-00004
Abstract
Results from the United Kingdom Prospective Diabetes Study showed that intensive treatment of type 2 (non-insulin—dependent) diabetes mellitus, with sulphonylureas or insulin, significantly reduced...This publication has 39 references indexed in Scilit:
- Insulin resistance and thrombosis: a cardiologist’s viewThe American Journal of Cardiology, 1999
- TroglitazoneDrugs, 1999
- GlimepirideDrugs, 1998
- Role of Sulfonylureas in Non-Insulin-Dependent Diabetes Mellitus: Part I - “The pros”Hormone and Metabolic Research, 1996
- Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)Drugs, 1995
- Comparative Tolerability Profiles of Oral Antidiabetic AgentsDrug Safety, 1994
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993
- Pathophysiology of vascular disease in diabetes: Effects of gliclazideThe American Journal of Medicine, 1991
- Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM PatientsDiabetes Care, 1990
- The Effect of Glibenclamide and Metformin on Serum Lipoproteins in Type 2 DiabetesDiabetic Medicine, 1988